ADP February 2026 Options Begin Trading

Automatic Data Processing (ADP) is trading at $258.35 and Stock Options Channel highlights two option strategies: selling the $255 put (bid $4.40) which nets an effective cost basis of $250.60 and represents a 1.73% return on cash (14.31% annualized) with a 59% chance to expire worthless; and selling a $260 covered call (bid $6.10) on shares bought at $258.35 which yields a 3.00% total return to $260 (2.36% premium boost, 19.59% annualized) with a 51% chance to expire worthless. Implied volatilities are ~22% for the put and ~24% for the call versus a 12-month realized/trailing volatility of 20%, and the outlet will track odds and contract histories on its contract detail pages.

Analysis

Market structure: The option prices imply mild risk-off around ADP — IV (22–24%) is ~2–4 pts above realized 20%, signaling slight premium for tail protection. Option sellers (income managers, retail covered-call writers) benefit from positive carry: cash‑secured 255 puts yield 1.73% (14.3% annualized) and 260 covered calls yield 2.36% (19.6% annualized) to expiry Feb‑2026. Large fiduciary buyers who need low-vol equity exposure will preferentially buy ADP vs higher-beta HR-tech names, supporting relative demand for ADP equity and short-dated premium.

Risk assessment: Tail risks include a payroll-processing outage/data breach (operational), recession-driven client churn (financial) or sustained P/E compression if rates reprice higher (regulatory/market). Short term (days–months) option sellers face assignment around quarterly payroll cycles or earnings; medium term (6–12 months) macro-driven hiring slowdowns could knock 8–15% off the stock; long term ADP’s recurring revenue and scale mitigate the downside but not cybersecurity/regulatory shocks. Hidden dependency: assignment forces capital deployment and potential tax-lot issues; IV re-pricing (spike >30%) would make rolling expensive.

Trade implications: Direct plays — favor disciplined income strategies: sell cash‑secured 255 Feb‑2026 puts or buy+sell 260 covered calls sized to desired exposure (target 1–4% portfolio per trade). Relative value — long ADP vs short high‑multiple HR SaaS (e.g., WDAY) to harvest defensive carry if hiring cools; target 6–12 month mean reversion of 10–20% relative. If volatility is key, sell premium (calendar or vertical spreads) given IV>realized but cap downside with put spreads or collars.

Contrarian angles: Consensus underestimates the asymmetric benefit to option sellers from low realized vol; selling premium is modestly underpriced. The market may be underreacting to ADP’s operational optionality (workforce analytics, Marketplace) that can re-accelerate revenue absent macro growth — a positive catalyst. Overdone risk: retail piling into income trades could create squeeze/assignment concentrations at strikes 1–3% from spot. Unintended consequence: aggressive put-selling without capital allocation rules can force post-crash buying at unfavorable bases (e.g., sub‑$240).

Key Decisions for Investors

• Sell-to-open cash‑secured ADP Feb‑2026 255 puts for ~$4.40 premium (net effective cost basis $250.60) sized to 1–3% of portfolio; plan: if assigned, hold 12–18 months or sell covered calls; cut/roll if ADP < $240 (limit loss ~5–7% of portfolio allocation).
• Buy 100 ADP shares (~$258.35) and sell-to-open Feb‑2026 260 covered call for ~$6.10 to capture ~3.0% to expiry (target position 2–4% portfolio); buy a protective Feb‑2026 250 put if downside protection desired (>~$1.50 premium tolerance) to create a collar before major payroll/earnings announcements.
• Establish a small pair trade: long ADP (1% portfolio) financed by short WDAY (0.5% notional) to express defensive payroll exposure vs high‑multiple HR SaaS; target 10–15% relative outperformance over 6–12 months and take profits if spread moves in that direction.
• If selling premium broadly, prefer defined‑risk structures: sell Feb‑2026 255/245 put spreads instead of naked puts to cap downside, or stagger expiries (90–180d) to avoid concentrated assignment risk; avoid increasing exposure if IV spikes above 30% or if upcoming earnings show guide‑down signals.